nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—Cerebellar syndrome—Fluorouracil—head and neck cancer	0.0439	0.0716	CcSEcCtD
Miglustat—UGCG—parotid gland—head and neck cancer	0.0377	0.142	CbGeAlD
Miglustat—GBA2—saliva-secreting gland—head and neck cancer	0.0366	0.138	CbGeAlD
Miglustat—Memory loss—Fluorouracil—head and neck cancer	0.03	0.0489	CcSEcCtD
Miglustat—GBA2—trachea—head and neck cancer	0.0282	0.106	CbGeAlD
Miglustat—UGCG—trachea—head and neck cancer	0.0278	0.105	CbGeAlD
Miglustat—UGCG—lymphoid tissue—head and neck cancer	0.0243	0.0912	CbGeAlD
Miglustat—GBA2—thyroid gland—head and neck cancer	0.0223	0.084	CbGeAlD
Miglustat—UGCG—thyroid gland—head and neck cancer	0.022	0.0828	CbGeAlD
Miglustat—GBA2—head—head and neck cancer	0.0198	0.0745	CbGeAlD
Miglustat—UGCG—head—head and neck cancer	0.0195	0.0735	CbGeAlD
Miglustat—Polyneuropathy—Docetaxel—head and neck cancer	0.0195	0.0318	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—BCL2L1—head and neck cancer	0.0188	0.156	CbGpPWpGaD
Miglustat—Neuritis—Vinblastine—head and neck cancer	0.018	0.0293	CcSEcCtD
Miglustat—Numbness—Vinblastine—head and neck cancer	0.0162	0.0264	CcSEcCtD
Miglustat—Sensory loss—Vinblastine—head and neck cancer	0.0155	0.0253	CcSEcCtD
Miglustat—GBA2—lymph node—head and neck cancer	0.0139	0.0522	CbGeAlD
Miglustat—UGCG—lymph node—head and neck cancer	0.0137	0.0515	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—BCL2—head and neck cancer	0.0132	0.109	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—IL2—head and neck cancer	0.0116	0.0961	CbGpPWpGaD
Miglustat—Menstruation irregular—Docetaxel—head and neck cancer	0.0115	0.0187	CcSEcCtD
Miglustat—Tingling sensation—Fluorouracil—head and neck cancer	0.011	0.0179	CcSEcCtD
Miglustat—Numbness—Fluorouracil—head and neck cancer	0.0106	0.0173	CcSEcCtD
Miglustat—Sensory loss—Fluorouracil—head and neck cancer	0.0102	0.0166	CcSEcCtD
Miglustat—Neuritis—Docetaxel—head and neck cancer	0.00851	0.0139	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—head and neck cancer	0.00771	0.0638	CbGpPWpGaD
Miglustat—Depression—Vinblastine—head and neck cancer	0.00748	0.0122	CcSEcCtD
Miglustat—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00736	0.012	CcSEcCtD
Miglustat—Amnesia—Fluorouracil—head and neck cancer	0.0068	0.0111	CcSEcCtD
Miglustat—Haemoglobin—Vinblastine—head and neck cancer	0.00677	0.011	CcSEcCtD
Miglustat—Haemorrhage—Vinblastine—head and neck cancer	0.00674	0.011	CcSEcCtD
Miglustat—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00671	0.0109	CcSEcCtD
Miglustat—Hypoaesthesia—Vinblastine—head and neck cancer	0.0067	0.0109	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—head and neck cancer	0.0063	0.0521	CbGpPWpGaD
Miglustat—Haemoglobin—Hydroxyurea—head and neck cancer	0.00617	0.0101	CcSEcCtD
Miglustat—Influenza like illness—Docetaxel—head and neck cancer	0.00617	0.0101	CcSEcCtD
Miglustat—Haemorrhage—Hydroxyurea—head and neck cancer	0.00614	0.01	CcSEcCtD
Miglustat—Ataxia—Fluorouracil—head and neck cancer	0.00601	0.0098	CcSEcCtD
Miglustat—Neuropathy—Docetaxel—head and neck cancer	0.00597	0.00973	CcSEcCtD
Miglustat—GBA2—Metabolism—UROD—head and neck cancer	0.00593	0.0491	CbGpPWpGaD
Miglustat—Muscular weakness—Fluorouracil—head and neck cancer	0.00564	0.00919	CcSEcCtD
Miglustat—Chills—Hydroxyurea—head and neck cancer	0.00551	0.00899	CcSEcCtD
Miglustat—Ill-defined disorder—Vinblastine—head and neck cancer	0.00544	0.00887	CcSEcCtD
Miglustat—UGCG—Metabolism—UROD—head and neck cancer	0.00542	0.0449	CbGpPWpGaD
Miglustat—Malaise—Vinblastine—head and neck cancer	0.00529	0.00863	CcSEcCtD
Miglustat—Vertigo—Vinblastine—head and neck cancer	0.00527	0.00859	CcSEcCtD
Miglustat—Convulsion—Vinblastine—head and neck cancer	0.00508	0.00829	CcSEcCtD
Miglustat—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00496	0.00809	CcSEcCtD
Miglustat—Discomfort—Vinblastine—head and neck cancer	0.00493	0.00805	CcSEcCtD
Miglustat—Visual disturbance—Docetaxel—head and neck cancer	0.00487	0.00794	CcSEcCtD
Miglustat—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00483	0.00788	CcSEcCtD
Miglustat—Malaise—Hydroxyurea—head and neck cancer	0.00482	0.00787	CcSEcCtD
Miglustat—Thrombocytopenia—Vinblastine—head and neck cancer	0.00469	0.00764	CcSEcCtD
Miglustat—Convulsion—Hydroxyurea—head and neck cancer	0.00463	0.00756	CcSEcCtD
Miglustat—Pain in extremity—Docetaxel—head and neck cancer	0.00461	0.00752	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0046	0.0381	CbGpPWpGaD
Miglustat—Anorexia—Vinblastine—head and neck cancer	0.00456	0.00744	CcSEcCtD
Miglustat—Migraine—Docetaxel—head and neck cancer	0.00454	0.00741	CcSEcCtD
Miglustat—Discomfort—Hydroxyurea—head and neck cancer	0.0045	0.00734	CcSEcCtD
Miglustat—Haemoglobin—Fluorouracil—head and neck cancer	0.00444	0.00725	CcSEcCtD
Miglustat—Haemorrhage—Fluorouracil—head and neck cancer	0.00442	0.00721	CcSEcCtD
Miglustat—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0044	0.00718	CcSEcCtD
Miglustat—Ataxia—Docetaxel—head and neck cancer	0.00434	0.00708	CcSEcCtD
Miglustat—Paraesthesia—Vinblastine—head and neck cancer	0.0043	0.00701	CcSEcCtD
Miglustat—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00428	0.00698	CcSEcCtD
Miglustat—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00427	0.00697	CcSEcCtD
Miglustat—Abdominal pain upper—Docetaxel—head and neck cancer	0.00421	0.00687	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00421	0.0348	CbGpPWpGaD
Miglustat—Anorexia—Hydroxyurea—head and neck cancer	0.00416	0.00679	CcSEcCtD
Miglustat—Decreased appetite—Vinblastine—head and neck cancer	0.00416	0.00679	CcSEcCtD
Miglustat—Cramp muscle—Docetaxel—head and neck cancer	0.00415	0.00678	CcSEcCtD
Miglustat—Constipation—Vinblastine—head and neck cancer	0.00409	0.00668	CcSEcCtD
Miglustat—Pain—Vinblastine—head and neck cancer	0.00409	0.00668	CcSEcCtD
Miglustat—Feeling abnormal—Vinblastine—head and neck cancer	0.00394	0.00643	CcSEcCtD
Miglustat—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00391	0.00638	CcSEcCtD
Miglustat—Dyspepsia—Hydroxyurea—head and neck cancer	0.00384	0.00627	CcSEcCtD
Miglustat—Decreased appetite—Hydroxyurea—head and neck cancer	0.00379	0.00619	CcSEcCtD
Miglustat—Abdominal pain—Vinblastine—head and neck cancer	0.00378	0.00617	CcSEcCtD
Miglustat—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00377	0.00615	CcSEcCtD
Miglustat—Fatigue—Hydroxyurea—head and neck cancer	0.00376	0.00614	CcSEcCtD
Miglustat—Pain—Hydroxyurea—head and neck cancer	0.00373	0.00609	CcSEcCtD
Miglustat—Constipation—Hydroxyurea—head and neck cancer	0.00373	0.00609	CcSEcCtD
Miglustat—Weight decreased—Docetaxel—head and neck cancer	0.00361	0.00588	CcSEcCtD
Miglustat—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0036	0.00587	CcSEcCtD
Miglustat—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00348	0.00568	CcSEcCtD
Miglustat—Asthenia—Vinblastine—head and neck cancer	0.00343	0.0056	CcSEcCtD
Miglustat—Convulsion—Fluorouracil—head and neck cancer	0.00334	0.00544	CcSEcCtD
Miglustat—Diarrhoea—Vinblastine—head and neck cancer	0.00327	0.00534	CcSEcCtD
Miglustat—Discomfort—Fluorouracil—head and neck cancer	0.00324	0.00528	CcSEcCtD
Miglustat—Haemoglobin—Docetaxel—head and neck cancer	0.00321	0.00523	CcSEcCtD
Miglustat—Haemorrhage—Docetaxel—head and neck cancer	0.00319	0.00521	CcSEcCtD
Miglustat—Hypoaesthesia—Docetaxel—head and neck cancer	0.00318	0.00518	CcSEcCtD
Miglustat—Dizziness—Vinblastine—head and neck cancer	0.00316	0.00516	CcSEcCtD
Miglustat—Connective tissue disorder—Docetaxel—head and neck cancer	0.00314	0.00512	CcSEcCtD
Miglustat—Asthenia—Hydroxyurea—head and neck cancer	0.00313	0.00511	CcSEcCtD
Miglustat—Nervous system disorder—Fluorouracil—head and neck cancer	0.00308	0.00502	CcSEcCtD
Miglustat—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00308	0.00502	CcSEcCtD
Miglustat—Visual impairment—Docetaxel—head and neck cancer	0.00308	0.00502	CcSEcCtD
Miglustat—Vomiting—Vinblastine—head and neck cancer	0.00304	0.00496	CcSEcCtD
Miglustat—Headache—Vinblastine—head and neck cancer	0.003	0.00489	CcSEcCtD
Miglustat—Anorexia—Fluorouracil—head and neck cancer	0.00299	0.00488	CcSEcCtD
Miglustat—Diarrhoea—Hydroxyurea—head and neck cancer	0.00299	0.00487	CcSEcCtD
Miglustat—Eye disorder—Docetaxel—head and neck cancer	0.00298	0.00486	CcSEcCtD
Miglustat—Dizziness—Hydroxyurea—head and neck cancer	0.00289	0.00471	CcSEcCtD
Miglustat—Chills—Docetaxel—head and neck cancer	0.00286	0.00467	CcSEcCtD
Miglustat—Nausea—Vinblastine—head and neck cancer	0.00284	0.00464	CcSEcCtD
Miglustat—Insomnia—Fluorouracil—head and neck cancer	0.00284	0.00463	CcSEcCtD
Miglustat—Paraesthesia—Fluorouracil—head and neck cancer	0.00282	0.0046	CcSEcCtD
Miglustat—Mental disorder—Docetaxel—head and neck cancer	0.0028	0.00456	CcSEcCtD
Miglustat—Malnutrition—Docetaxel—head and neck cancer	0.00278	0.00453	CcSEcCtD
Miglustat—Vomiting—Hydroxyurea—head and neck cancer	0.00278	0.00453	CcSEcCtD
Miglustat—Dyspepsia—Fluorouracil—head and neck cancer	0.00277	0.00451	CcSEcCtD
Miglustat—Headache—Hydroxyurea—head and neck cancer	0.00273	0.00446	CcSEcCtD
Miglustat—Decreased appetite—Fluorouracil—head and neck cancer	0.00273	0.00445	CcSEcCtD
Miglustat—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00271	0.00442	CcSEcCtD
Miglustat—Back pain—Docetaxel—head and neck cancer	0.00269	0.00438	CcSEcCtD
Miglustat—Pain—Fluorouracil—head and neck cancer	0.00269	0.00438	CcSEcCtD
Miglustat—Muscle spasms—Docetaxel—head and neck cancer	0.00267	0.00436	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00262	0.0216	CbGpPWpGaD
Miglustat—Nausea—Hydroxyurea—head and neck cancer	0.00259	0.00423	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00259	0.0214	CbGpPWpGaD
Miglustat—Feeling abnormal—Fluorouracil—head and neck cancer	0.00259	0.00422	CcSEcCtD
Miglustat—GBA2—Metabolism—NAT2—head and neck cancer	0.00246	0.0204	CbGpPWpGaD
Miglustat—Convulsion—Docetaxel—head and neck cancer	0.00241	0.00393	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00239	0.0198	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00237	0.0196	CbGpPWpGaD
Miglustat—Dry mouth—Docetaxel—head and neck cancer	0.00231	0.00377	CcSEcCtD
Miglustat—UGCG—Metabolism—NAT2—head and neck cancer	0.00225	0.0186	CbGpPWpGaD
Miglustat—Nervous system disorder—Docetaxel—head and neck cancer	0.00222	0.00363	CcSEcCtD
Miglustat—Thrombocytopenia—Docetaxel—head and neck cancer	0.00222	0.00362	CcSEcCtD
Miglustat—Anorexia—Docetaxel—head and neck cancer	0.00216	0.00353	CcSEcCtD
Miglustat—GBA2—Metabolism—DPYD—head and neck cancer	0.00216	0.0179	CbGpPWpGaD
Miglustat—Diarrhoea—Fluorouracil—head and neck cancer	0.00215	0.00351	CcSEcCtD
Miglustat—Dizziness—Fluorouracil—head and neck cancer	0.00208	0.00339	CcSEcCtD
Miglustat—Insomnia—Docetaxel—head and neck cancer	0.00205	0.00334	CcSEcCtD
Miglustat—GBA2—Metabolism—YAP1—head and neck cancer	0.00205	0.0169	CbGpPWpGaD
Miglustat—Paraesthesia—Docetaxel—head and neck cancer	0.00204	0.00332	CcSEcCtD
Miglustat—Vomiting—Fluorouracil—head and neck cancer	0.002	0.00326	CcSEcCtD
Miglustat—Dyspepsia—Docetaxel—head and neck cancer	0.002	0.00326	CcSEcCtD
Miglustat—UGCG—Metabolism—DPYD—head and neck cancer	0.00198	0.0163	CbGpPWpGaD
Miglustat—Decreased appetite—Docetaxel—head and neck cancer	0.00197	0.00321	CcSEcCtD
Miglustat—Headache—Fluorouracil—head and neck cancer	0.00197	0.00321	CcSEcCtD
Miglustat—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00196	0.00319	CcSEcCtD
Miglustat—Fatigue—Docetaxel—head and neck cancer	0.00195	0.00319	CcSEcCtD
Miglustat—Constipation—Docetaxel—head and neck cancer	0.00194	0.00316	CcSEcCtD
Miglustat—Pain—Docetaxel—head and neck cancer	0.00194	0.00316	CcSEcCtD
Miglustat—UGCG—Metabolism—YAP1—head and neck cancer	0.00187	0.0155	CbGpPWpGaD
Miglustat—Feeling abnormal—Docetaxel—head and neck cancer	0.00187	0.00305	CcSEcCtD
Miglustat—Nausea—Fluorouracil—head and neck cancer	0.00187	0.00304	CcSEcCtD
Miglustat—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00185	0.00302	CcSEcCtD
Miglustat—Abdominal pain—Docetaxel—head and neck cancer	0.00179	0.00292	CcSEcCtD
Miglustat—Asthenia—Docetaxel—head and neck cancer	0.00163	0.00265	CcSEcCtD
Miglustat—Diarrhoea—Docetaxel—head and neck cancer	0.00155	0.00253	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00154	0.0127	CbGpPWpGaD
Miglustat—Dizziness—Docetaxel—head and neck cancer	0.0015	0.00245	CcSEcCtD
Miglustat—Vomiting—Docetaxel—head and neck cancer	0.00144	0.00235	CcSEcCtD
Miglustat—Headache—Docetaxel—head and neck cancer	0.00142	0.00232	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00141	0.0116	CbGpPWpGaD
Miglustat—Nausea—Docetaxel—head and neck cancer	0.00135	0.0022	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00134	0.0111	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TYMS—head and neck cancer	0.00123	0.0102	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00123	0.0102	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTM1—head and neck cancer	0.00122	0.0101	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GPX1—head and neck cancer	0.00116	0.00963	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP1A1—head and neck cancer	0.00115	0.00954	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TYMS—head and neck cancer	0.00113	0.00931	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTM1—head and neck cancer	0.00111	0.0092	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GPX1—head and neck cancer	0.00107	0.00881	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP1A1—head and neck cancer	0.00105	0.00872	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000947	0.00783	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000866	0.00717	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS2—head and neck cancer	0.000686	0.00567	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS2—head and neck cancer	0.000627	0.00519	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTEN—head and neck cancer	0.000598	0.00495	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—head and neck cancer	0.000547	0.00452	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CA—head and neck cancer	0.000422	0.00349	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—head and neck cancer	0.000386	0.00319	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—head and neck cancer	0.000345	0.00285	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—head and neck cancer	0.000315	0.00261	CbGpPWpGaD
